Comparing common doses (double-dose vs usual-dose) of atorvastatin for preventing contrast-induced acute kidney injury and mortality after coronary angiography

High-dose atorvastatin pretreatment was proved reducing the risk of contrast-induced acute kidney injury (CI-AKI), especially in patients with high C-reactive protein (CRP) levels. We evaluated the effects of common atorvastatin doses (double vs usual) on the risk of CI-AKI and mortality. We recorde...

Descripción completa

Detalles Bibliográficos
Autores principales: Bei, Wei-Jie, Chen, Shi-Qun, Li, Hua-Long, Wu, Deng-Xuan, Duan, Chongyang, Chen, Ping-Yan, Chen, Ji-Yan, Tan, Ning, Xie, Nian-Jin, Liu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627819/
https://www.ncbi.nlm.nih.gov/pubmed/28746193
http://dx.doi.org/10.1097/MD.0000000000007501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627819/
https://www.ncbi.nlm.nih.gov/pubmed/28746193
http://dx.doi.org/10.1097/MD.0000000000007501

Ejemplares similares